Vertex Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Vertex Pharma (VRTX) Tops Q3 EPS by 5c; bumps guidance
November 6, 2023 4:02 PM ESTVertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $3.97, $0.05 better than the analyst estimate of $3.92. Revenue for the quarter came in at $2.48 billion versus the consensus estimate of $2.5 billion.
GUIDANCE:
Vertex Pharma sees FY2023 revenue of $9.85 billion, versus prior guidance of... More
